Pharmacotherapy of insomnia with ramelteon : safety, efficacy and clinical applications
Abstract: Ramelteon is a tricyclic synthetic analog of melatonin that acts specifically on MT1 and MT2 melatonin receptors. Ramelteon is the first melatonin receptor agonist approved by the Food and Drug Administration (FDA) for the treatment of insomnia characterized by sleep onset difficulties. Ra...
Guardado en:
| Autores principales: | Pandi Perumal, Seithikurippu R., Spence, David Warren, Verster, Joris C., Srinivasan, Venkataramanujan, Brown, Gregory M., Cardinali, Daniel Pedro, Hardeland, Rüdiger |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés Inglés |
| Publicado: |
Libertas Academica
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/1646 |
| Aporte de: |
Ejemplares similares
-
Melatonin and its analogs in insomnia and depression
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Jet lag, circadian rhythm sleep disturbances and depression : the role of melatonin and its analogs
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019) -
Some implications of melatonin use in chronopharmacology of insomnia
por: Golombek, Diego A., et al.
Publicado: (2019) -
Melatonin and its agonist ramelteon in Alzheimer's disease : possible therapeutic value
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019) -
Melatonin agonists in primary insomnia and depression-associated insomnia : are they superior to sedative-hypnotics?
por: Srinivasan, Venkataramanujan, et al.
Publicado: (2019)